Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Cited by
Items 301–400 of 707
Joshi, B., Ordonez‐Ercan, D., Dasgupta, P., & Chellappan, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208206 · Cited by 42
DNA-binding independent cell death from a minimal proapoptotic region of E2F-1
Bell, L. A., O’Prey, J., & Ryan, K. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209580 · Cited by 42
“In addition, E2F-1 has also been shown to directly transactivate components of the apoptotic machinery such as apoptosis protein activating factor (Apaf-1), and caspase 7 (Moroni et al., 2001; Furukawa et al., 2002; Nahle et al., 2002).”
BackgroundMethodResultLibertini, S. J., Tepper, C. G., Guadalupe, M., Lü, Y., Asmuth, D. M., & Mudryj, M. M. (2005) · The Prostate · doi:10.1002/pros.20314 · Cited by 42
Ruiz‐Ruiz, C., Robledo, G., Cano, E., Redondo, J. M., & López‐Rivas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304397200 · Cited by 41
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function
Britschgi, A., Trinh, E., Rizzi, M., Jenal, M., Ress, A., Tobler, A., Fey, M. F., Helin, K., & Tschan, M. P. (2008) · Oncogene · doi:10.1038/onc.2008.179 · Cited by 41
“, 2006), 35% for Noxa (Hershko and Ginsberg, 2004), 60% for Apaf-1 (Moroni et al., 2001) or 50% for DIP (Stanelle et al.”
BackgroundSelf-citationWilson, C., Henry, S. E., Smith, M. A., & Bowser, R. P. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00496.x · Cited by 41
“E2F1 and proteins of the p53 gene family regulate expression of proteins including Apaf-1, cytochrome c and bax that function in mitochondrial-induced cell death [15].”
BackgroundAge-Dependent Susceptibility of the Retinal Ganglion Cell Layer to Cell Death
McKernan, D. P., Caplis, C., Donovan, M., O'Brien, C. J., & Cotter, T. G. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0520 · Cited by 41
A Structural Analysis of the Qualitative Networks Regulating the Cell Cycle and Apoptosis
Aguda, B. D., & Algar, C. K. (2003) · Cell Cycle · doi:10.4161/cc.2.6.550 · Cited by 40
Regulation of E2F1-induced Apoptosis by the Nucleolar Protein RRP1B
Paik, J. C., Wang, B., Liu, K., Lue, J. K., & Lin, W.-C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072074 · Cited by 40
Repression of Androgen Receptor Transcription through the E2F1/DNMT1 Axis
Valdez, C. D., Davis, J. N., Odeh, H. M., Layfield, T. L., Cousineau, C. S., Berton, T. R., Johnson, D. G., Wojno, K. J., & Day, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025187 · Cited by 40
“E2F1 binding sites have been reported in the promoters of the breast cancer susceptibility gene BRCA1 [23], p73 [24,25], the tumor suppressor gene p14 [26], and the gene for apoptosis proteaseactivating factor 1 (Apaf-1) [27].”
BackgroundWallace, D., & Cotter, T. G. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21910 · Cited by 39
“It has been shown that Apaf-1 is a direct transcriptional target for both E2F-1 and p53, (Moroni et al., 2001) and furthermore is a mediator of E2F-1-induced apoptosis (Furukawa et al.”
BackgroundResultInfluentialEnhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1
Deng, W., Wu, G., Ueda, K., Xu, K., Roth, J. A., & Ji, L. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701094 · Cited by 39
Linking of N-Myc to Death Receptor Machinery in Neuroblastoma Cells
Cui, H., Li, T., & Ding, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410450200 · Cited by 39
Essential postmitochondrial function of p53 uncovered in DNA damage-induced apoptosis in neurons
Vaughn, A. E., & Deshmukh, M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402084 · Cited by 39
“Recently, p53 has also been identified as a transcriptional activator of Apaf-1, but the importance of this activity has remained unclear.(24,31) As the increase in Apaf-1 could be a potential mechanism by which XIAP is relieved to permit neuronal apoptosis, we investigated the specific importance of p53 in this proce…”
BackgroundHernández‐Ortega, K., Quiroz‐Baez, R., & Arias, C. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1002-z · Cited by 38
Lu, H., & Hallstrom, T. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447276 · Cited by 38
“4 GO:0016572 [9]: histone phosphorylation 0.”
Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt
Niit, M., Hoskin, V., Carefoot, E., Geletu, M., Arulanandam, R., Elliott, B. E., & Raptis, L. H. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0022 · Cited by 38
Nuclear Apaf‐1 and cytochrome c redistribution following stress‐induced apoptosis
Ruiz‐Vela, A., de Buitrago, G. G., & Martínez‐A, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02607-8 · Cited by 38
Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma
Umetani, N., Fujimoto, A., Takeuchi, H., Shinozaki, M., Bilchik, A. J., & Hoon, D. S. �. (2004) · Oncogene · doi:10.1038/sj.onc.1208022 · Cited by 38
A New Role for E2F-1 in Checkpoint Control
Stevens, C., & Thangue, N. B. L. (2003) · Cell Cycle · doi:10.4161/cc.2.5.462 · Cited by 38
Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer
Ansari, N., Shahrabi, S., Khosravi, A., Shirzad, R., & Rezaeean, H. (2019) · Laboratory Medicine · doi:10.1093/labmed/lmz009 · Cited by 37
Tumor promotion by caspase-resistant retinoblastoma protein
Borges, H. L., Bird, J., Wasson, K., Cardiff, R. D., Varki, N. M., Eckmann, L., & Wang, J. Y. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503925102 · Cited by 36
TAp73 Is a Downstream Target of p53 in Controlling the Cellular Defense against Stress
Wang, J., Liu, Y., Hande, M. P., Wong, A. C., Jin, Y. J., & Yin, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703408200 · Cited by 35
E2F1 as a Target: Promoter-Driven Suicide and Small Molecule Modulators
Kaelin, W. G. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.202 · Cited by 35
E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila
Wichmann, A., Uyetake, L., & Su, T. T. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.07.023 · Cited by 34
“…transcriptionally induce pro-apoptotic genes including p73, Apaf1 and caspase 3 and is sufficient to induce p53-independent apoptosis both in cultured mammalian cells and in vivo in mouse testes (Holmberg et al., 1998; Irwin et al., 2000; Moroni et al., 2001; Nahle et al., 2002; Shu et al., 2000).”
Krepela, E. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1397 · Cited by 34
“Both epigenetic and transcriptional factor-mediated regulation of Apaf-1 and PC-9 expression levels plays an important role in predisposition of cells to activate the apoptosome apparatus (4-8).”
BackgroundHsu, T., Chu, C., Hung, M., Lee, H., Hsu, H., & Chang, T. (2013) · FEBS Journal · doi:10.1111/febs.12242 · Cited by 34
A combinatorial mechanism for determining the specificity of E2F activation and repression
Freedman, J. A., Chang, J. T., Jakoi, L., & Nevins, J. R. (2009) · Oncogene · doi:10.1038/onc.2009.153 · Cited by 35
“…important for cellular proliferation, E2F1 also signals an apoptotic program (Bates et al., 1998; Croxton et al., 2002; DeGregori et al., 1997; Hallstrom and Nevins, 2006; Irwin et al., 2000; Lissy et al., 2000; Moroni et al., 2001; Nahle et al., 2002; Rogoff et al., 2004; Stiewe and Putzer, 2000).”
BackgroundSalazar, G., Joshi, A. R., Liu, D., Wei, H., Persson, J. L., & Wolgemuth, D. J. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20533 · Cited by 34
“Other than the Bcl-2 family members, p53 has also been demonstrated to up-regulate Apaf-1 gene expression (Kannan et al., 2000; Moroni et al., 2001; Robles et al., 2001).”
BackgroundWang, J., Yin, D. P., Liu, Y.-X., Baer, R. J., & Yin, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4402 · Cited by 34
“The current model is that E2F-1 can regulate p73 and Apaf-1, both of which are mediators of apoptosis (15, 16, 36).”
BackgroundMeyer, K., Basu, A., Saito, K., Ray, R. B., & Ray, R. (2005) · Virology · doi:10.1016/j.virol.2005.03.016 · Cited by 34
E2F Modulates Keratinocyte Squamous Differentiation
Wong, C. F., Barnes, L. M., Dahler, A. L., Smith, L., Serewko-Auret, M. M., Popa, C., Jabbar, I. A., & Saunders, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301246200 · Cited by 34
The regulation of APAF1 expression during development and tumourigenesis
Hickman, E. S., & Helin, K. (2002) · APOPTOSIS · doi:10.1023/a:1014370616864 · Cited by 34
Self-citationA novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity
Gasri-Plotnitsky, L., Ovadia, A., Shamalov, K., Nizri-Megnaji, T., Meir, S., Zurer, I., Cohen, C. J., & Ginsberg, D. (2017) · Oncotarget · doi:10.18632/oncotarget.15864 · Cited by 33
“The plasmids pBabe-neo-HA-ER-E2F1, pBabepuro-HA-ERE2F1-E132 [38, 39], pBABE-puro-16E7, pBABE-puro-E7-dl21-35, prcCMV-HA-E2F1(E132), were used.”
Constitutive and induced functions of the p53 gene
Zheltukhin, A. O., & Chumakov, P. M. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910130110 · Cited by 33
E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit
Ingram, L., Munro, S., Coutts, A. S., & Thangue, N. B. L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.70 · Cited by 33
“protease-activating factor 1 (Apaf1), Cdc6, p73 and cyclin E.(5,21) Although each promoter was activated by E2F-1, coexpressing DP-4 resulted in reduced levels of transcription”
BackgroundAntiapoptotic Signaling Pathways in Non–Small-Cell Lung Cancer: Biology and Therapeutic Strategies
Haura, E. B., Cress, W. D., Chellappan, S., Zheng, Z., & Bepler, G. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.n.025 · Cited by 33
Calabrò, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., & Mantia, G. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8529-8540.2004 · Cited by 33
“the last C-terminal 609 bp of TAp63 , whereas Np63 (1-26) and Np63 (1-”
BackgroundWallace, D., Donovan, M., & Cotter, T. G. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1383 · Cited by 33
“One possible mechanism is that TSA activates E2F-1, which then may act on the promoters of target genes.(23,24) The precise mechanism in place has yet to be elucidated.”
BackgroundCao, W., Zhang, J.-L., Feng, D., Liu, X.-W., Li, Y., Wang, L., Yao, L.-B., Zhang, H., & Zhang, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.096 · Cited by 32
Dingar, D. D., Konecny, F. A., Zou, J., Sun, X., & von Harsdorf, R. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.004 · Cited by 32
“Our study delivers substantial experimental evidence that E2F4 and p130 are transcriptional repressors on the promoters of crucial apoptosis-inducing genes (E2F1, p73, Apaf-1) [20,25,26].”
BackgroundCell Cycle Proteins as Key Regulators of Postmitotic Cell Death.
Xia, P., Liu, Y., Chen, J., & Cheng, Z. (2019) · PubMed Central · Cited by 32
E2F6 Inhibits Cobalt Chloride-Mimetic Hypoxia-induced Apoptosis through E2F1
Yang, W., Shu, B., Zhu, Y., & Yang, H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0171 · Cited by 34
“During apoptosis, Apaf-1 assembles with cytochrome c, a mitochondrial protein released upon apoptotic signals, and activates procaspase-9, leading to the activation of downstream effector caspases, including caspase-3, caspase-6, and caspase-7 (Moroni et al., 2001; Furukawa et al., 2002).”
BackgroundExpression of apoptosome pathway-related transcripts in non-small cell lung cancer
Krepela, E., Procházka, J., Fiala, P., Zatloukal, P., & Selinger, P. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0048-6 · Cited by 32
“Although the expression of Apaf-1 gene can be transcriptionally upregulated through overexpression of E2F-1 and wild-type p53 (Müller et al. 2001; Moroni et al. 2001; Robles et al. 2001; Furukawa et al. 2002) and both transcriptional factors are frequently overexpressed in NSCLCs (Gorgoulis et al.…”
BackgroundInfluentialSala, D. L., Macaluso, M., Trimarchi, C., Giordano, A., & Cinti, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206487 · Cited by 31
Avivi, A., Ashur‐Fabian, O., Amariglio, N., Nevo, E., & Rechavi, G. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1534 · Cited by 31
Cell Death in Brain Development and Degeneration: Control of Caspase Expression May Be Key!
Madden, S. D., & Cotter, T. G. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8021-4 · Cited by 31
“E2F-1 is negatively regulated by retinoblastoma (Rb) [55] and by histone deacetylase (HDAC) [58].”
BackgroundAdenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma
Ternovoi, V. V., Curiel, D. T., Smith, B. F., & Siegal, G. P. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700444 · Cited by 31
Defects in G1‐S cell cycle control in head and neck cancer: A review
Michalides, R. J. A. M., van den Brekel, M. W. M., & Balm, F. J. M. (2002) · Head & Neck · doi:10.1002/hed.10109 · Cited by 31
A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53
Stanelle, J., Tu-Rapp, H., & Pützer, B. M. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401532 · Cited by 31
“E2F1, for example, transactivates the gene encoding the apoptosis protease-activating factor 1 (Apaf1).(32) This initiates the assembly of Apaf1 with cytochrome c (cyt c) followed by procaspase-9 activation and successive initiation of proapoptotic effector caspases such as caspase-3.”
BackgroundFaour, W. H., He, Q., Mancini, A. D., Jovanović, D., Battista, J. A. D., & Battista, J. A. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601293200 · Cited by 31
The downregulation of the RNA-binding protein Staufen2 in response to DNA damage promotes apoptosis
Zhang, X., Trépanier, V., Beaujois, R., Viranaïcken, W., Drobetsky, E. A., & DesGroseillers, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw057 · Cited by 30
“As further controls, APAF1 and GRP78 mRNA, known to be upregulated and not to be regulated, respectively, following DNA damage (40) responded as expected (Figure 1C).”
BackgroundHauck, L., Kaba, R. G., Lipp, M., Dietz, R., & von Harsdorf, R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2147-2158.2002 · Cited by 30
“Except for amino acid residue 213, where GABP 1 carries an additional valine, GABP 1 (1-332) shares an identical amino acid sequence with the corresponding GABP 1 protein.”
BackgroundMethodInfluentialThe Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy
Shachar, B. B., Feldstein, O., Hacohen, D., & Ginsberg, D. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0137 · Cited by 30
“org occurs through both p53-dependent and p53-independent pathways, and it has been shown that a number of E2F1regulated genes, including p14/p19ARF, p73, Apaf-1, caspases, and BH3-only proteins, contribute to E2Finduced apoptosis (9-16).”
BackgroundModeling the response of a tumor-suppressive network to mitogenic and oncogenic signals
Tian, X., Huang, B. Y., Zhang, X., Lu, M., Liu, F., Onuchic, J. N., & Wang, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702412114 · Cited by 30
Jori, F. P., Melone, M. A. B., Napolitano, M. A., Cipollaro, M., Cascino, A., Giordano, A., & Galderisi, U. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401499 · Cited by 30
Differential regulation of apoptotic genes by Rb in human versus mouse cells
Young, A. P., & Longmore, G. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207330 · Cited by 30
Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
Lieschke, E., Wang, Z., Kelly, G. L., & Strasser, A. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy077 · Cited by 30
Engaged for survival: From cadherin ligation to STAT3 activation
Geletu, M., Guy, S., Arulanandam, R., Feracci, H., & Raptis, L. H. (2013) · JAK-STAT · doi:10.4161/jkst.27363 · Cited by 29
Cellular and Molecular Mechanisms of Apoptosis in Age-Related Muscle Atrophy
Dirks‐Naylor, A. J., & Lennon-Edwards, S. (2012) · Current Aging Science · doi:10.2174/1874609811104030269 · Cited by 29
Kikuchi, J., Shimizu, R., Wada, T., Ando, H., Nakamura, M., Ozawa, K., & Furukawa, Y. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0207 · Cited by 29
Besse, B., Candé, C., Spano, J., Martin, A., Khayat, D., Chevalier, T. L., Tursz, T., Sabatier, L., Soria, J., & Kroemer, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0415 · Cited by 29
“Both of them are functionally related to Apaf-1, p53 as a transcription factor that stimulates Apaf-1 expression at the mRNA level (35) and Hsp70 as an Apaf-1-binding inhibitor of apoptosome formation (36–38).”
BackgroundThe DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage
Zio, D. D., Bordi, M., Tino, E., Lanzuolo, C., Ferraro, E., Mora, E. M., Ciccosanti, F., Fimia, G. M., Orlando, V., & Cecconi, F. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.125 · Cited by 28
Self-citationHoffmann, A., & Spengler, D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00842-08 · Cited by 28
“The promoter plasmids were pGL3b, Apaf-1 ( 871/ 208) (24), p21(WWP-Luc) (11), and”
Xia, Y., Cheng, J., Liu, Y., Li, C., Liu, Y., & Liu, P. (2021) · Genomics · doi:10.1016/j.ygeno.2021.12.013 · Cited by 28
Dipeptidyl Peptidase 2 is an essential survival factor in the regulation of cell quiescence
Mele, D. A., Bista, P., Baez, D. V., & Huber, B. T. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9144 · Cited by 28
E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3
Chen, D., Chen, Y., Forrest, D., & Bremner, R. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.24 · Cited by 28
“Later work showed all three induce apoptosis of Rat1 fibroblasts,(10) although E2f1 was the most potent effector.(11) Transgenic E2f1 or E2f3a overexpression enhances skin apoptosis,(12,13) as does E2f1, E2f2 or E2f3a expression in lens,(14,15) but whereas E2f1 or E2f3 stimulate cardiomyocyte division and death, E2f2…”
BackgroundThe Role of the E2F Transcription Factor Family in UV-Induced Apoptosis
Hazar-Rethinam, M. H., Endo‐Munoz, L., Gannon, O. M., & Saunders, N. A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128947 · Cited by 28
“The p53-dependent pathway involves the stabilization of p53 via p14/p19 ARF [78] whilst activation of APAF1 and p73 or CHK2 is required for p53-independent apoptosis [79–81].”
BackgroundAbsence of pRb facilitates E2F1-induced apoptosis in breast cancer cells
Sun, B., Wingate, H. F., Swisher, S. G., Keyomarsi, K., & Hunt, K. K. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10990 · Cited by 28
Irofulven induces replication-dependent CHK2 activation related to p53 status
Wang, Y., Wiltshire, T. D., Senft, J., Reed, E., & Wang, W. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.023 · Cited by 28
“Additional studies indicated that CHK2 induces apoptosis by activating E2F1, which in turn up-regulates its target genes INK4a/ARF, Apaf-1, caspase-7, p73 and p53 [24-26].”
BackgroundEngelmann, D., Knoll, S., Ewerth, D., Steder, M., Stoll, A., & Pützer, B. M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0222-0 · Cited by 27
Kimura, J., Kudoh, T., Miki, Y., & Yoshida, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.25475 · Cited by 27
He, J., Feng, X., Hua, J., Li, W., Lü, Z., Wei, W.-J., Cai, H., Wang, B., Shi, W., Ding, N., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1367070 · Cited by 27
Xiao, Q., Li, L., Xie, Y., Tan, N., Wang, C., Xu, J., Xia, K., Gardner, K. L., & Li, Q. Q. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/147615 · Cited by 27
“Third, E2F-1 signals apoptosis independently of p53 via direct transcriptional activation of the apoptotic protease-activating factor-1 (Apaf-1) gene [56] and the p53 family member p73 [57,58], which are direct targets for E2F-1.”
BackgroundTFDP3 inhibits E2F1-induced, p53-mediated apoptosis
Tian, C., Lv, D., Qiao, H., Zhang, J., Yin, Y., Qian, X., Wang, Y., Zhang, Y., & Chen, W. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.128 · Cited by 27
E2F activity is essential for survival of Myc-overexpressing human cancer cells
Santoni‐Rugiu, E., Duro, D., Farkas, T., Mathiasen, I. S., Jäättelä, M., Bártek, J., & Lukas, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205828 · Cited by 27
“Interestingly, in this respect, recent work has shown that increased expression of E2Fs induces not only proapoptotic genes (Moroni et al., 2001; Müller et al., 2001) but also antiapoptotic genes and survival/ growth factors, such as Bcl2 and TGF-a (Müller et al., 2001), which can inhibit…”
BackgroundActivation of Cell Cycle Arrest and Apoptosis by the Proto-Oncogene Pim-2
Levy, D., Davidovich, A., Zirkin, S., Frug, Y., Cohen, A. M., Shalom, S., & Don, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034736 · Cited by 27
Strachan, G. D., Koike, M. A., Siman, R., Hall, D. J., & Jordan‐Sciutto, K. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20574 · Cited by 26
“, 1999], Apaf-1 [Moroni et al., 2001], and p73 [Stiewe and Putzer, 2000].”
BackgroundInfluentialα-Tocopheryl succinate induces cytostasis and apoptosis in osteosarcoma cells: the role of E2F1
Alleva, R., Benassi, M. S., Tomasetti, M., Gellert, N., Ponticelli, F., Borghi, B., Picci, P., & Neužil, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.080 · Cited by 26
Emerging Pathogenic Role for Cyclin Dependent Kinases in Neurodegeneration
Smith, P. D., O'Hare, M. J., & Park, D. S. (2004) · Cell Cycle · doi:10.4161/cc.3.3.706 · Cited by 26
Redmond, W. L., Wei, C., Kreuwel, H. T. C., & Sherman, L. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5275 · Cited by 25
“E2F1 was initially of interest as a candidate apoptosis-inducing molecule based its ability to directly up-regulate several down-stream proapoptotic molecules, including Bim and Apaf-1 (28, 38).”
BackgroundCyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury
Liem, D. A., Zhao, P., Angelis, E., Chan, S. S., Zhang, J., Wang, G., Berthet, C., Kaldis, P., Ping, P., & MacLellan, W. R. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.07.003 · Cited by 25
“E2F-1 regulates a number of genes involved in the apoptotic cascade including p53 family member, p73 [24], Apaf-1 [25,26], cytochrome c [27] and caspase-3,-7,-8 and -9 [28].”
BackgroundTumour suppressors—a fly's perspective
Sutcliffe, J. E., Korenjak, M., & Brehm, A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00263-6 · Cited by 25
“In human cells, p53-independent apoptosis following pRb inactivation has been attributed to the upregulation of E2F target genes such as the p53 family member p73 and the apoptotic protease-activating factor 1 (APAF1) [57–59].”
BackgroundArsad, H., Adebayo, I. A., & Samian, M. R. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_125_18 · Cited by 24
Insights into the Mitochondrial Signaling Pathway: What Lessons for Chemotherapy?
Brenner, C., Bras, M. L., & Kroemer, G. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1022541009662 · Cited by 24
Activation pathways and signal-mediated upregulation of the insect Spodoptera frugiperda caspase-1
Liu, Q., & Chejanovsky, N. (2006) · APOPTOSIS · doi:10.1007/s10495-006-5059-5 · Cited by 24
Isolation and characterization of DUSP11, a novel p53 target gene
Caprara, G., Zamponi, R., Melixetian, M. B., & Helin, K. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00616.x · Cited by 24
“Using this technology we have reported on the identification of APAF1 (apoptosis protease activating factor 1) as a p53 target gene [17].”
MethodSelf-citationThe p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 24
“Apaf1 was found by three independent groups to be a transcriptional target of p53 (Moroni et al., 2001; Robles et al., 2001; Rozenfeld-Granot et al., 2002).”
BackgroundMolecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Peták, I., Houghton, J. A., & Kopper, L. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269217 · Cited by 24
Apaf-1 expression in malignant melanoma
Soengas, M. S., Gerald, W. L., Cordon‐Cardo, C., Lazebnik, Y. A., & Lowe, S. W. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401755 · Cited by 24
Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53
Löber, C., Lenz-Stöppler, C., & Dobbelstein, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-2047 · Cited by 24
“…et al., 1997), MCG10 (Zhu & Chen, 2000) and Reprimo (Ohki et al., 2000), as well as inducers of apoptosis, such as Apaf-1 (Kannan et al., 2001 ; Moroni et al., 2001), Killer}DR5 (Wu et al., 1997), MCG10 (Zhu & Chen, 2000), Noxa (Oda et al., 2000a), p53AIP1 (Oda et al., 2000b), PUMA (Nakano &…”
InfluentialSasse, S. K., & Gerber, A. N. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.004 · Cited by 23
“…in regulatory hierarchies of plant (Saddic et al., 2006), animal (Duggan et al., 1998; Davidson et al., 2002; Iranfar et al., 2006), and even human (Moroni et al., 2001; Mullen et al., 2002; Boyer et al., 2005; Swiers et al., 2006; Krejci et al., 2009) cells, suggesting an important role for this…”
BackgroundLiu, R., Fu, C., Sun, J., Wang, X., Geng, S., Wang, X., Zou, J., Bi, Z., & Yang, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456598 · Cited by 23
Transcriptional activation of APAF1 by KAISO (ZBTB33) and p53 is attenuated by RelA/p65
Koh, D., An, H., Kim, M., Jeon, B., Choi, S., Hur, S. S., & Hur, M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.008 · Cited by 23
Targeting Rb inactivation in cancers by synthetic lethality.
Gordon, G. M., & Du, W. (2011) · PubMed · Cited by 24
Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis
Ho, C. K., & Li, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06810.x · Cited by 23
Attardi, L. D., & Sage, J. (2013) · Genes & Development · doi:10.1101/gad.219451.113 · Cited by 23
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers
Chung, J., & Knutson, B. A. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00751-5 · Cited by 22
Karimzadeh, S., Hosseinkhani, S., Fathi, A., Ataei, F., & Baharvand, H. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.01.005 · Cited by 22
Liu, H., Knabb, J. R., Spike, B. T., & Macleod, K. F. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0439 · Cited by 22
“However, this does not resolve whether pRb is acting directly to repress death genes or indirectly by blocking the cell cycle as E2Fs have been shown to regulate both cell cycle genes (7, 8) and cell death genes such as Apaf-1, caspases, p73, and Bim (9-12).”
Background
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.